Opportunity Information: Apply for PA 06 443

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Human Biospecimen Resources for Aging Research (R03)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
  • This funding opportunity was created on Dec 5, 2008 and posted on May 31, 2006.
  • Applicants must submit their applications by Sep 7, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $50,000.00 in funding.
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Public and State controlled institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Independent school districts County governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments City or township governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply. Applicants may submit more than one application, provided each application is scientifically distinct. Applicants must include a letter from the Principal Investigator(s) of the studies containing the biospecimens of interest, confirming the availability of the biospecimens for the proposed project.
Apply for PA 06 443

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Human Biospecimen Resources for Aging Research (R03) opportunity (Funding Opportunity Number PA 06 443) is an NIH program announcement designed to help researchers make practical use of already-existing human biospecimen collections for aging-related studies. Rather than funding the creation of new specimen banks, the main goal is to spread awareness of biospecimen resources that already exist and to encourage independent investigators to pursue pilot projects by partnering or otherwise coordinating with the established studies that collected those specimens in the first place. The participating collections and study websites are organized through the National Institute on Aging (NIA) Virtual Repository, which serves as a central entry point for identifying what biospecimens are available and which cohorts or studies maintain them.

Scientifically, the announcement emphasizes aging research that combines biomarker work with broader, real-world phenotypic information. NIA highlights interests that connect biological measures (for example, molecular, genetic, proteomic, metabolic, inflammatory, endocrine, or other biomarker analyses) with questions about normal aging, common age-associated diseases, and the kinds of behavioral and psychosocial data often captured in longitudinal cohorts. The intent is to support research that can take advantage of rich existing datasets linked to stored samples, allowing investigators to explore new hypotheses or test feasibility before moving toward larger-scale projects. In other words, this R03 is positioned as a pilot and exploratory pathway meant to open up new directions, validate methods, and generate preliminary findings that could justify subsequent, more extensive funding.

The funding mechanism is the NIH R03 small grant, and the announcement specifies an award ceiling of $50,000. The activity category is health, under CFDA 93.866 (Aging Research), and there is no cost-sharing or matching requirement. The overall structure reflects a small, targeted investment meant to catalyze innovative secondary use of valuable biospecimen resources, especially where the major costs relate to assays, sample handling fees, data access arrangements, and focused analytic work rather than building new infrastructure.

Eligibility is broad across many U.S.-based organization types, including public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (other than small businesses), state and local governments (including county and city/township governments), special district governments, independent school districts, public housing authorities/Indian housing authorities, and eligible federal agencies. Tribal governments and tribal organizations are also included. Faith-based and community-based organizations may apply as well. A key restriction is that foreign institutions are not eligible to apply. Applicants are allowed to submit more than one application as long as each proposed project is scientifically distinct.

A notable application requirement is documentation of access: applicants must include a letter from the principal investigator(s) of the study or studies that control the biospecimens being requested. That letter must confirm that the biospecimens needed for the proposed project are available. This requirement reinforces that the program expects investigators to have already initiated coordination with the cohort or repository managers and to have a credible plan for obtaining the materials and any associated data necessary to complete the pilot study.

Administratively, the opportunity was posted May 31, 2006 (with a later creation date listed as December 5, 2008), used multiple receipt dates, and had a last listed closing date of September 7, 2009, with an archive date of October 7, 2009. The sponsoring agency is the National Institutes of Health, with NIA as the driving institute behind the biospecimen repository focus. The full announcement was available through the NIH grants guide at the provided link, and NIH’s Office of Extramural Research webmaster contact is listed for technical access issues.

FAQs: Human Biospecimen Resources for Aging Research (R03) - NIH (PA 06-443)

What is the Human Biospecimen Resources for Aging Research (R03) opportunity (PA 06-443)?

This is an NIH program announcement that supports small, pilot-scale aging research projects that make practical use of already-existing human biospecimen collections. It is designed to help investigators access and use stored human samples that were collected by established studies, rather than creating new specimen banks.

What is the main purpose of this program announcement?

The main goal is to increase awareness and use of existing biospecimen resources and to encourage independent investigators to pursue pilot and exploratory projects by partnering or coordinating with the studies that originally collected and maintain those biospecimens.

Does this opportunity fund the creation of new biospecimen banks or collections?

No. The announcement emphasizes secondary use of already-existing biospecimen collections. It is not intended to fund the creation of new specimen banks or new large-scale collection infrastructure.

Where can applicants identify which biospecimens and cohorts are available?

The participating collections and study websites are organized through the National Institute on Aging (NIA) Virtual Repository, which is described as a central entry point for identifying available biospecimens and the cohorts/studies that maintain them.

What kinds of research topics does the announcement emphasize?

The announcement emphasizes aging research that combines biomarker work with broader, real-world phenotypic information. NIA highlights interests that connect biological measures with questions about normal aging, common age-associated diseases, and behavioral and psychosocial data often captured in longitudinal cohort studies.

What types of biomarker analyses are explicitly mentioned as examples?

Examples listed include molecular, genetic, proteomic, metabolic, inflammatory, endocrine, and other biomarker analyses.

Why is this opportunity framed as a pilot or exploratory pathway?

The R03 mechanism is positioned here to help investigators explore new hypotheses, test feasibility, validate methods, and generate preliminary findings using existing samples and linked datasets. The intent is to support early-stage work that could justify later, larger-scale projects.

What funding mechanism is used for this opportunity?

The funding mechanism is the NIH R03 small grant.

What is the maximum award amount (award ceiling) stated in the announcement?

The announcement specifies an award ceiling of $50,000.

Is cost-sharing or matching required?

No. The opportunity states there is no cost-sharing or matching requirement.

What costs does this opportunity seem intended to support?

Based on the description, it is structured as a small, targeted investment where major costs are likely to include assays, sample handling fees, data access arrangements, and focused analytic work, rather than building new infrastructure.

What is the activity category and CFDA number listed for this opportunity?

The activity category is health, and the CFDA number is 93.866 (Aging Research).

Who is eligible to apply?

Eligibility is broad across many U.S.-based organization types, including public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses); state and local governments (including county and city/township governments); special district governments; independent school districts; public housing authorities/Indian housing authorities; eligible federal agencies; tribal governments; and tribal organizations. Faith-based and community-based organizations may also apply.

Are foreign institutions eligible to apply?

No. A key restriction stated is that foreign institutions are not eligible to apply.

Can an applicant submit more than one application under this announcement?

Yes. Applicants are allowed to submit more than one application as long as each proposed project is scientifically distinct.

What is a notable application documentation requirement related to biospecimen access?

Applicants must include a letter from the principal investigator(s) of the study or studies that control the biospecimens being requested. The letter must confirm that the biospecimens needed for the proposed project are available.

Why is the letter confirming biospecimen availability required?

The requirement reinforces that investigators are expected to initiate coordination with the cohort or repository managers in advance and to present a credible plan for obtaining the biospecimens and any associated data needed to complete the pilot project.

What role does the National Institute on Aging (NIA) play in this opportunity?

NIA is the driving institute behind the biospecimen repository focus described in the announcement, including the organization of participating collections through the NIA Virtual Repository.

When was this opportunity posted and when did it close (as listed)?

The opportunity was posted on May 31, 2006. It used multiple receipt dates, had a last listed closing date of September 7, 2009, and an archive date of October 7, 2009. A later creation date is also listed as December 5, 2008.

Where was the full announcement made available?

The full announcement was available through the NIH grants guide at the provided link referenced in the description.

Who is listed for technical access issues related to the announcement?

NIH's Office of Extramural Research webmaster contact is listed for technical access issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: The Development of Frontal Cortex and Limbic System and their roles in Drug Abuse or Mental Health (R21)

Previous opportunity: Shared Neurobiology of Fragile X Syndrome and Autism (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 06 443

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 06 443) also looked into and applied for these:

Funding Opportunity
Research Opportunities in Stuttering (R21) Apply for PA 06 482

Funding Number: PA 06 482
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Oral Health Research Education Grants (R25) Apply for PAR 06 506

Funding Number: PAR 06 506
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Phased Innovation Awards in AIDS Vaccine Research (R21/R33) Apply for PA 06 519

Funding Number: PA 06 519
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Immunology of Biofilms (R21) Apply for PA 06 538

Funding Number: PA 06 538
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
MBRS Research Initiative for Scientific Enhancement (RISE) (R25) Apply for PAR 06 548

Funding Number: PAR 06 548
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Initiative for Maximizing Student Diversity (IMSD)(R25) Apply for PAR 06 553

Funding Number: PAR 06 553
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Studies of Bisphoshonate Therapy and Osteonecrosis of the Jaws (R21) Apply for PAR 06 556

Funding Number: PAR 06 556
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Community Based Participatory Research at NIMH (R21) Apply for PAR 07 004

Funding Number: PAR 07 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Demonstration and Dissemination Grants (R18) Apply for PA 07 017

Funding Number: PA 07 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Mild and/or Unilateral Hearing Loss (R21) Apply for PA 07 037

Funding Number: PA 07 037
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Erythroid Lineage Molecular Toolbox (R01) Apply for PA 07 011

Funding Number: PA 07 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Alcohol and HIV/AIDS (R01) Apply for PA 07 028

Funding Number: PA 07 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Alcohol and HIV/AIDS (R21) Apply for PA 07 063

Funding Number: PA 07 063
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Alcohol and HIV/AIDS (R03) Apply for PA 07 064

Funding Number: PA 07 064
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Use Disorders Treatment, Services Research, and Recovery (R01) Apply for PA 07 066

Funding Number: PA 07 066
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01) Apply for PA 07 059

Funding Number: PA 07 059
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Insulin Signaling And Receptor Cross Talk (R01) Apply for PA 07 058

Funding Number: PA 07 058
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Right Heart Function in Health and Chronic Lung Diseases (R01) Apply for PA 07 043

Funding Number: PA 07 043
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Mild and/or Unilateral Hearing Loss (R01) Apply for PA 07 038

Funding Number: PA 07 038
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) Apply for PA 07 050

Funding Number: PA 07 050
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 06 443", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.